169 related articles for article (PubMed ID: 35163394)
21. Mutation screening of fumarate hydratase by multiplex ligation-dependent probe amplification: detection of exonic deletion in a patient with leiomyomatosis and renal cell cancer.
Ahvenainen T; Lehtonen HJ; Lehtonen R; Vahteristo P; Aittomäki K; Baynam G; Dommering C; Eng C; Gruber SB; Grönberg H; Harvima R; Herva R; Hietala M; Kujala M; Kääriäinen H; Sunde L; Vierimaa O; Pollard PJ; Tomlinson IP; Björck E; Aaltonen LA; Launonen V
Cancer Genet Cytogenet; 2008 Jun; 183(2):83-8. PubMed ID: 18503824
[TBL] [Abstract][Full Text] [Related]
22. Novel splice site mutation in the fumarate hydratase (FH) gene is associated with multiple cutaneous leiomyomas in a Japanese patient.
Yoshinaga Y; Nakai H; Hayashi R; Ito A; Kariya N; Ito M; Shimomura Y
J Dermatol; 2016 Jan; 43(1):85-91. PubMed ID: 26173633
[TBL] [Abstract][Full Text] [Related]
23. Mutations in the fumarate hydratase gene cause hereditary leiomyomatosis and renal cell cancer in families in North America.
Toro JR; Nickerson ML; Wei MH; Warren MB; Glenn GM; Turner ML; Stewart L; Duray P; Tourre O; Sharma N; Choyke P; Stratton P; Merino M; Walther MM; Linehan WM; Schmidt LS; Zbar B
Am J Hum Genet; 2003 Jul; 73(1):95-106. PubMed ID: 12772087
[TBL] [Abstract][Full Text] [Related]
24. Fumarate hydratase mutations and predisposition to cutaneous leiomyomas, uterine leiomyomas and renal cancer.
Alam NA; Olpin S; Leigh IM
Br J Dermatol; 2005 Jul; 153(1):11-7. PubMed ID: 16029320
[TBL] [Abstract][Full Text] [Related]
25. Missense mutations in fumarate hydratase in multiple cutaneous and uterine leiomyomatosis and renal cell cancer.
Alam NA; Olpin S; Rowan A; Kelsell D; Leigh IM; Tomlinson IP; Weaver T
J Mol Diagn; 2005 Oct; 7(4):437-43. PubMed ID: 16237213
[TBL] [Abstract][Full Text] [Related]
26. Immunohistochemistry for 2-Succinocysteine (2SC) and Fumarate Hydratase (FH) in Cutaneous Leiomyomas May Aid in Identification of Patients With HLRCC (Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome).
Buelow B; Cohen J; Nagymanyoki Z; Frizzell N; Joseph NM; McCalmont T; Garg K
Am J Surg Pathol; 2016 Jul; 40(7):982-8. PubMed ID: 26945337
[TBL] [Abstract][Full Text] [Related]
27. Association of germline mutations in the fumarate hydratase gene and uterine fibroids in women with hereditary leiomyomatosis and renal cell cancer.
Stewart L; Glenn GM; Stratton P; Goldstein AM; Merino MJ; Tucker MA; Linehan WM; Toro JR
Arch Dermatol; 2008 Dec; 144(12):1584-92. PubMed ID: 19075141
[TBL] [Abstract][Full Text] [Related]
28. Strong family history of uterine leiomyomatosis warrants fumarate hydratase mutation screening.
Tolvanen J; Uimari O; Ryynänen M; Aaltonen LA; Vahteristo P
Hum Reprod; 2012 Jun; 27(6):1865-9. PubMed ID: 22473397
[TBL] [Abstract][Full Text] [Related]
29. Fumarate hydratase c.914T > C (p.Phe305Ser) is a pathogenic variant associated with hereditary leiomyomatosis and renal cell cancer syndrome.
Breen KE; Carlo MI; Kemel Y; Maio A; Chen YB; Zhang L; Ceyhan-Birsoy O; Mandelker D
Mol Genet Genomic Med; 2020 Aug; 8(8):e1293. PubMed ID: 32463173
[TBL] [Abstract][Full Text] [Related]
30. No evidence for epigenetic inactivation of fumarate hydratase in leiomyomas and leiomyosarcomas.
Barker KT; Spendlove HE; Banu NS; Bridge JA; Fisher C; Shipley J; Garrett M; Manyonda I; Houlston RS
Cancer Lett; 2006 Apr; 235(1):136-40. PubMed ID: 15949892
[TBL] [Abstract][Full Text] [Related]
31. Renal cell carcinoma in young FH mutation carriers: case series and review of the literature.
Hol JA; Jongmans MCJ; Littooij AS; de Krijger RR; Kuiper RP; van Harssel JJT; Mensenkamp A; Simons M; Tytgat GAM; van den Heuvel-Eibrink MM; van Grotel M
Fam Cancer; 2020 Jan; 19(1):55-63. PubMed ID: 31792767
[TBL] [Abstract][Full Text] [Related]
32. Fumarate hydratase gene mutation in two young patients with sporadic uterine fibroids.
Kubinova K; Tesarova M; Hansikova H; Vesela K; Kuzel D; Mara M
J Obstet Gynaecol Res; 2013 Jan; 39(1):410-4. PubMed ID: 22764886
[TBL] [Abstract][Full Text] [Related]
33. Fumarate Hydratase Mutation in a Young Woman With Uterine Leiomyomas and a Family History of Renal Cell Cancer.
Mann ML; Ezzati M; Tarnawa ED; Carr BR
Obstet Gynecol; 2015 Jul; 126(1):90-2. PubMed ID: 25923021
[TBL] [Abstract][Full Text] [Related]
34. Multiple cutaneous leiomyomas leading to discovery of novel splice mutation in the fumarate hydratase gene associated with HLRCC.
Tan RYP; Walsh M; Howard A; Winship I
Australas J Dermatol; 2017 Nov; 58(4):e246-e248. PubMed ID: 28266706
[TBL] [Abstract][Full Text] [Related]
35. Uterine leiomyomas in hereditary leiomyomatosis and renal cell cancer (HLRCC) syndrome can be identified through distinct clinical characteristics and typical morphology.
Uimari O; Ahtikoski A; Kämpjärvi K; Butzow R; Järvelä IY; Ryynänen M; Aaltonen LA; Vahteristo P; Kuismin O
Acta Obstet Gynecol Scand; 2021 Nov; 100(11):2066-2075. PubMed ID: 34480341
[TBL] [Abstract][Full Text] [Related]
36. Molecular pathways: Fumarate hydratase-deficient kidney cancer--targeting the Warburg effect in cancer.
Linehan WM; Rouault TA
Clin Cancer Res; 2013 Jul; 19(13):3345-52. PubMed ID: 23633457
[TBL] [Abstract][Full Text] [Related]
37. [Hereditary leiomyomatosis and renal cell cancer - HLRCC/multiple cutaneous and uterine leimomyomatosis - MCUL].
Plevová P; Hladíková A; Tesařová M
Klin Onkol; 2012; 25 Suppl():S55-8. PubMed ID: 22920208
[TBL] [Abstract][Full Text] [Related]
38. Detailed Morphologic and Immunohistochemical Characterization of Myomectomy and Hysterectomy Specimens From Women With Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome (HLRCC).
Chan E; Rabban JT; Mak J; Zaloudek C; Garg K
Am J Surg Pathol; 2019 Sep; 43(9):1170-1179. PubMed ID: 31162287
[TBL] [Abstract][Full Text] [Related]
39. No evidence for the role of somatic mutations and promoter hypermethylation of FH gene in the tumorigenesis of nonsyndromic uterine leiomyomas.
Vaidya S; Shaik NA; Latha M; Chava S; Mohiuddin K; Yalla A; Rao KP; Kodati VL; Hasan Q
Tumour Biol; 2012 Oct; 33(5):1411-8. PubMed ID: 22528940
[TBL] [Abstract][Full Text] [Related]
40. Utility of prospective pathologic evaluation to inform clinical genetic testing for hereditary leiomyomatosis and renal cell carcinoma.
Kopp RP; Stratton KL; Glogowski E; Schrader KA; Rau-Murthy R; Russo P; Coleman JA; Offit K
Cancer; 2017 Jul; 123(13):2452-2458. PubMed ID: 28171700
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
